ZA744259B - Topical steroid - Google Patents

Topical steroid

Info

Publication number
ZA744259B
ZA744259B ZA00744259A ZA744259A ZA744259B ZA 744259 B ZA744259 B ZA 744259B ZA 00744259 A ZA00744259 A ZA 00744259A ZA 744259 A ZA744259 A ZA 744259A ZA 744259 B ZA744259 B ZA 744259B
Authority
ZA
South Africa
Prior art keywords
topical steroid
steroid
topical
Prior art date
Application number
ZA00744259A
Other languages
English (en)
Inventor
C Krieger
W Shultz
M Sieger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA744259B publication Critical patent/ZA744259B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00744259A 1973-08-17 1974-07-02 Topical steroid ZA744259B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38930273A 1973-08-17 1973-08-17

Publications (1)

Publication Number Publication Date
ZA744259B true ZA744259B (en) 1975-06-25

Family

ID=23537694

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00744259A ZA744259B (en) 1973-08-17 1974-07-02 Topical steroid

Country Status (17)

Country Link
US (1) US4158055A (fr)
JP (1) JPS557407B2 (fr)
BE (1) BE818929A (fr)
CH (1) CH601353A5 (fr)
CY (1) CY946A (fr)
DE (1) DE2437847C3 (fr)
FR (1) FR2240738B1 (fr)
GB (1) GB1442925A (fr)
HK (1) HK44778A (fr)
HU (1) HU172213B (fr)
IE (1) IE39738B1 (fr)
IL (1) IL45200A (fr)
KE (1) KE2820A (fr)
MY (1) MY7800234A (fr)
NL (1) NL184899C (fr)
PH (1) PH12415A (fr)
ZA (1) ZA744259B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA763131B (en) * 1975-05-27 1978-01-25 Syntex Inc Use of flunisolide to treat respiratory diseases
DE10326899A1 (de) * 2003-06-14 2004-12-30 Beiersdorf Ag Kosmetische Zubereitungen mit stabilisierten Konservierungsmitteln
AU2004268847A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
WO2005028495A1 (fr) * 2003-09-24 2005-03-31 Glaxo Group Limited Glucocorticoïdes anti-inflammatoires
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
EP1934219A1 (fr) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
EP1948167A1 (fr) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions d'inhibiteurs de la phosphodiesterase de type iv
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
AU2007298549A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
WO2008111009A1 (fr) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
AU2008224541B2 (en) * 2007-03-14 2013-08-22 Sun Pharmaceutical Industries Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN113698448B (zh) * 2021-10-29 2022-02-22 山东谷雨春生物科技有限公司 一种安西奈德的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB894810A (en) * 1959-10-05 1962-04-26 American Cyanamid Co Aqueous pharmaceutical solutions containing anti-inflammatory steroids
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
GB928150A (en) * 1961-02-08 1963-06-06 Upjohn Co Topical pharmaceutical compositions comprising steroids and flavonoids
US3053836A (en) * 1961-07-14 1962-09-11 Olin Mathieson Acetals and ketals of 16alpha, 17alpha-dihydroxyprogesterones
US3541602A (en) * 1968-07-29 1970-11-17 Squibb & Sons Inc Acetonides of 9-halogenated 3beta,11beta,10alpha,17alpha,21-pentahydroxypregnanes
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base

Also Published As

Publication number Publication date
NL184899C (nl) 1989-12-01
HK44778A (en) 1978-08-18
NL184899B (nl) 1989-07-03
PH12415A (en) 1979-02-07
DE2437847C3 (de) 1981-03-12
US4158055A (en) 1979-06-12
DE2437847A1 (de) 1975-02-27
AU7073674A (en) 1976-01-08
BE818929A (fr) 1975-02-17
DE2437847B2 (de) 1980-06-19
JPS557407B2 (fr) 1980-02-25
IL45200A0 (en) 1974-11-29
IE39738L (en) 1975-02-17
JPS5058211A (fr) 1975-05-21
KE2820A (en) 1978-03-10
CH601353A5 (fr) 1978-07-14
CY946A (en) 1978-06-23
FR2240738A1 (fr) 1975-03-14
GB1442925A (en) 1976-07-14
IL45200A (en) 1978-08-31
HU172213B (hu) 1978-07-28
MY7800234A (en) 1978-12-31
FR2240738B1 (fr) 1980-04-11
IE39738B1 (en) 1978-12-20
NL7410613A (nl) 1975-02-19

Similar Documents

Publication Publication Date Title
CY1009A (en) Topical compositions
ZA745602B (en) Steroidal topical cream base
ZA744259B (en) Topical steroid
PH11410A (en) Novel steroids
MY8100216A (en) Phenyl-alkenones
ZA748000B (en) Anti-inflammatory agents
AU7373674A (en) D-homo-steroids
CA1015742A (en) Steroids
ZA744737B (en) Isomerisation
AU6566574A (en) Photoelectrophoresis
ZA745197B (en) Novel d-homo steroids
GB1408549A (en) Digitoxigenin alpha-l-arabinoside derivatives
ZA745315B (en) Novel steroids
IE39471L (en) Chlorothio-n-phthalimide; intermediate
JPS5133436A (en) Jitenshano sokoryokufukasochi
AU6420174A (en) Steroids
AU489087B2 (en) n TOPICAL STEROID
AU463919B2 (en) 17-alkadienyl steroid
AU477992B2 (en) Steroids
AU463920B2 (en) 17-alkadienyl substituted steroids
GB1483944A (en) 4,5-seco steroids
AU7144674A (en) Raodstone
AU5649073A (en) Gradio-gravimeter gradio-gravimeter
AU6458974A (en) Ointment
AU480546B2 (en) Novel steroids